Changes to the Medicare and Medicaid programs, including rebate structures and formularies, coverage, pharmacy reimbursement for generic drugs under Medicaid. Issues relating to MIPPA prompt pay requirements and reimbursement to independent pharmacies.  HR 4213 American Jobs and Closing Loopholes Act of 2010. Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment.  Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies.  HR 4199  Patient Health and Real Medication Access Cost Savings Act of 2009;  HR 5234  PBM Audit Reform and Transparency Act of 2010. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model. HR 1204 - Community Pharmacy Fairness Act of 2009 Issues relating to the delivery of the prescription drug benefit portion of FEHBP.  HR 4489 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act.
MMM - Medicare/Medicaid HCR - Health Issues GOV - Government Issues
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ALSTON & BIRD LLP
THE ATLANTIC BUILDING, 950 F STREET, NW, WASHINGTON, DC, 20004, US
THOMAS A SCULLY TIMOTHY P TRYSLA JENNIFER L BUTLER STEPHANIE A KENNAN MARK RAYDER THOMAS A SCULLY TIMOTHY P TRYSLA JENNIFER L BUTLER STEPHANIE A KENNAN MARK RAYDER THOMAS A SCULLY TIMOTHY P TRYSLA JENNIFER L BUTLER STEPHANIE A KENNAN MARK RAYDER